CDKN2A and acute lymphoblastic leukemia: With regard to biallelic loss of CDKN2A, no significant association with CFZ sensitivity was observed in 79 BCP-ALL cell lines and in 65 Ph-negative BCP-ALL cell lines (data not shown).